BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30385188)

  • 1. Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.
    Roberts KJ; Bannister CA; Schrem H
    Pancreatology; 2019 Jan; 19(1):114-121. PubMed ID: 30385188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the treatment of pancreatic exocrine insufficiency on survival of patients with unresectable pancreatic cancer: a retrospective analysis.
    Domínguez-Muñoz JE; Nieto-Garcia L; López-Díaz J; Lariño-Noia J; Abdulkader I; Iglesias-Garcia J
    BMC Cancer; 2018 May; 18(1):534. PubMed ID: 29728096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreas exocrine replacement therapy is associated with increased survival following pancreatoduodenectomy for periampullary malignancy.
    Roberts KJ; Schrem H; Hodson J; Angelico R; Dasari BVM; Coldham CA; Marudanayagam R; Sutcliffe RP; Muiesan P; Isaac J; Mirza DF
    HPB (Oxford); 2017 Oct; 19(10):859-867. PubMed ID: 28711377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
    J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of Appropriate Use of Pancreatic Enzyme Replacement Therapy and Symptomatic Response in Pancreatic Cancer Patients.
    Barkin JA; Westermann A; Hoos W; Moravek C; Matrisian L; Wang H; Shemanski L; Barkin JS; Rahib L
    Pancreas; 2019 Jul; 48(6):780-786. PubMed ID: 31210656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Multicenter Open-Label Randomized Controlled Trial of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer.
    Saito T; Nakai Y; Isayama H; Hirano K; Ishigaki K; Hakuta R; Takeda T; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Takahara N; Hamada T; Uchino R; Mizuno S; Mouri D; Yagioka H; Kogure H; Togawa O; Matsubara S; Ito Y; Yamamoto N; Tada M; Koike K
    Pancreas; 2018 Aug; 47(7):800-806. PubMed ID: 29851751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic enzyme replacement therapy following surgery for pancreatic cancer: An exploration of patient self-management.
    Dunleavy L; Al-Mukhtar A; Halliday V
    Clin Nutr ESPEN; 2018 Aug; 26():97-103. PubMed ID: 29908691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of pancreatic exocrine replacement therapy for patients with unresectable pancreatic cancer in a randomized trial.
    Woo SM; Joo J; Kim SY; Park SJ; Han SS; Kim TH; Koh YH; Chung SH; Kim YH; Moon H; Hong EK; Lee WJ
    Pancreatology; 2016; 16(6):1099-1105. PubMed ID: 27618657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer.
    Powell-Brett S; de Liguori Carino N; Roberts K
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt A):539-544. PubMed ID: 32178962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency.
    Layer P; Kashirskaya N; Gubergrits N
    World J Gastroenterol; 2019 May; 25(20):2430-2441. PubMed ID: 31171887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, anthropometric and laboratory nutritional markers of pancreatic exocrine insufficiency: Prevalence and diagnostic use.
    Lindkvist B; Phillips ME; Domínguez-Muñoz JE
    Pancreatology; 2015; 15(6):589-97. PubMed ID: 26243045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Pancreatic Enzyme Replacement Therapy in Unresectable Pancreatic Cancer: A Prospective Cohort Study.
    Saito T; Hirano K; Isayama H; Nakai Y; Saito K; Umefune G; Akiyama D; Watanabe T; Takagi K; Hamada T; Takahara N; Uchino R; Mizuno S; Kogure H; Matsubara S; Yamamoto N; Tada M; Koike K
    Pancreas; 2017 Mar; 46(3):341-346. PubMed ID: 28099252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent.
    Forsmark CE; Tang G; Xu H; Tuft M; Hughes SJ; Yadav D
    Aliment Pharmacol Ther; 2020 May; 51(10):958-967. PubMed ID: 32249970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert opinion on management of pancreatic exocrine insufficiency in pancreatic cancer.
    Roeyen G; Berrevoet F; Borbath I; Geboes K; Peeters M; Topal B; Van Cutsem E; Van Laethem JL
    ESMO Open; 2022 Feb; 7(1):100386. PubMed ID: 35124465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: an open-label, multicentre, single-treatment-arm study.
    Graff GR; McNamara J; Royall J; Caras S; Forssmann K
    Clin Drug Investig; 2010; 30(6):351-64. PubMed ID: 20441244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of pancreatic enzyme replacement therapy on short- and long-term outcomes in advanced pancreatic cancer: meta-analysis of randomized controlled trials.
    Ammar K; Leeds JS; Ratnayake CB; Sen G; French JJ; Nayar M; Oppong KW; Loveday BP; Pandanaboyana S
    Expert Rev Gastroenterol Hepatol; 2021 Aug; 15(8):941-948. PubMed ID: 33522321
    [No Abstract]   [Full Text] [Related]  

  • 19. Pancreatic enzyme replacement therapy (PERT) for malabsorption in patients with metastatic pancreatic cancer.
    Landers A; Muircroft W; Brown H
    BMJ Support Palliat Care; 2016 Mar; 6(1):75-9. PubMed ID: 25164613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic Enzyme Replacement Therapy in Children with Severe Acute Malnutrition: A Randomized Controlled Trial.
    Bartels RH; Bourdon C; Potani I; Mhango B; van den Brink DA; Mponda JS; Muller Kobold AC; Bandsma RH; Boele van Hensbroek M; Voskuijl WP
    J Pediatr; 2017 Nov; 190():85-92.e2. PubMed ID: 28912050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.